BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3 AND Treatment
34413 results:

  • 1. Contemporary outcomes for resected type 1-3 gastroesophageal junction adenocarcinoma: a single-center experience.
    Stiles ZE; Hagerty BL; Brady M; Mukherjee S; Hochwald SN; Kukar M
    J Gastrointest Surg; 2024 May; 28(5):634-639. PubMed ID: 38704200
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Surgical vs nonsurgical treatment for esophageal squamous cell carcinoma in patients older than 70 years: a propensity score matching analysis.
    Li K; Li C; Nie X; He W; Du K; Liu K; Wang C; Li J; Han Y; Peng L; Wang Q; Leng X
    J Gastrointest Surg; 2024 May; 28(5):611-620. PubMed ID: 38704198
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Effects of concurrent chemoradiotherapy with or without Endostar on the regression of retropharyngeal lymph node and prognosis of patients with locally advanced nasopharyngeal carcinoma: a retrospective study.
    Song JM; Mo N; Lv YQ; Huang LL; Wen YJ; Liu T; Li ZR; Wang RS; Zhang TT
    J Cancer Res Clin Oncol; 2024 May; 150(5):232. PubMed ID: 38703186
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Efficacy of Episil® in patients with hematologic malignancies: a comparative study.
    Fukutani T; Yoshioka Y; Imori S; Yanagihara H; Sumi K; Myoken Y; Fujita Y; Yanamoto S
    BMC Oral Health; 2024 May; 24(1):522. PubMed ID: 38698387
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Systematic review and meta-analysis: the efficacy and safety of radiofrequency ablation for early superficial esophageal squamous cell neoplasia.
    Cheng HE; Shiu SI; Ko CW
    BMC Gastroenterol; 2024 May; 24(1):152. PubMed ID: 38698314
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Our experience with robotic-assisted thymic surgery.
    Podhráský M; Tvrdoň J; Schützner J
    Rozhl Chir; 2024; 103(2):40-47. PubMed ID: 38697812
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Phosphaturic mesenchymal tumor-induced bilateral osteomalacia femoral neck fractures: a case report.
    Zhang Y; Hu M; Guo C; Yang X; Xiang S; Xu H
    Front Endocrinol (Lausanne); 2024; 15():1373794. PubMed ID: 38689735
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The role of the soft palate dose regarding normal tissue toxicities in older adults with head and neck cancer undergoing definitive radiotherapy.
    Bitz HC; Sachpazidis I; Zou J; Schnell D; Baltas D; Grosu AL; Nicolay NH; Rühle A
    Radiat Oncol; 2024 Apr; 19(1):53. PubMed ID: 38689338
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Clinical Impact of the Pretreatment Albumin to Fibrinogen Ratio in Esophageal cancer Patients Who Receive Curative treatment.
    Aoyama T; Maezawa Y; Hashimoto I; Hara K; Kazama K; Komori K; Kato A; Otani K; Tamagawa A; Cho H; Morita J; Kawahara S; Tanabe M; Oshima T; Saito A; Yukawa N; Rino Y
    In Vivo; 2024; 38(3):1253-1259. PubMed ID: 38688590
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Radiotherapy for patients with esophageal cancer aged 80 years or older: A 16-year experience.
    Zhai T; Huang R; Zhan Y; Xu L; Yu Y; Guo L; Chen J; Su C; Chen C
    J Cancer Res Ther; 2024 Apr; 20(2):678-683. PubMed ID: 38687940
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Facial nerve protection in surgery for rare tumors of the internal auditory canal].
    Yang B; Xie P; Xu Y; Yang X; Ren J; Liu T; Jiang Y; Hua Q
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 May; 38(5):400-404;410. PubMed ID: 38686477
    [No Abstract]    [Full Text] [Related]  

  • 12. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
    Wan Q; Tan L; Tang X; Wang W; Su Y; Wu Z; Ke M; Chen Z
    Front Endocrinol (Lausanne); 2024; 15():1327766. PubMed ID: 38686207
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.
    Pasternak B; Wintzell V; Hviid A; Eliasson B; Gudbjörnsdottir S; Jonasson C; Hveem K; Svanström H; Melbye M; Ueda P
    BMJ; 2024 Apr; 385():e078225. PubMed ID: 38683947
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
    Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Outcomes of Induction Chemotherapy Followed by Chemoradiotherapy Versus Chemoradiotherapy Alone in Esophageal Squamous Cell Carcinoma Induction chemotherapy in Esophageal Squamous Cell Carcinoma.
    Hosseini Toudeshki S; Garousi M; Arefpour AM; Fadavi P; Basi A; Foroughi A; Javadinia SA
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1183-1188. PubMed ID: 38679976
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Biological functions of LncRNA SNHG14 in the development of thyroid cancer cells via targeting miR-206.
    Sang Y; Min R; Huang T; Zhang J
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):77-84. PubMed ID: 38678623
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comparison of endoscopic thyroidectomy via the oral vestibule approach and the areola approach for papillary thyroid carcinoma.
    Liu Y; Lin F; Yan W; Lin E; Kuang P; Hong X; Lu Y; Wu G; Li L
    BMC Surg; 2024 Apr; 24(1):127. PubMed ID: 38678205
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal cancer Cell Lines Regardless of HPV Status.
    Lukoceviciute M; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
    Anticancer Res; 2024 May; 44(5):1863-1876. PubMed ID: 38677772
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The Prognostic Immune and Nutritional Indices Are Independent Prognostic Factors for Esophageal cancer Patients Who Receive Curative treatment.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kato A; Kazama K; Tamagawa A; Cho H; Nakazono M; Numata M; Kawahara S; Oshima T; Saito A; Yukawa N
    Anticancer Res; 2024 May; 44(5):2185-2192. PubMed ID: 38677744
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Promising Approaches in Plant-Based Therapies for Thyroid cancer: An Overview of In Vitro, In Vivo, and Clinical Trial Studies.
    Kaczmarzyk I; Nowak-Perlak M; Woźniak M
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674046
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1721.